Caribou Biosciences (CRBU) Operating Income (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64% |
| Dec 31, 2025 | 3.22% |
| Sep 30, 2025 | 38.21% |
| Jun 30, 2025 | -10.87% |
| Mar 31, 2025 | -10.39% |
| Dec 31, 2024 | -1.67% |
| Sep 30, 2024 | 12.10% |
| Jun 30, 2024 | 5.44% |
| Mar 31, 2024 | -22.86% |
| Dec 31, 2023 | -155.87% |
| Sep 30, 2023 | 55.48% |
| Jun 30, 2023 | -5.63% |
| Mar 31, 2023 | -1.76% |
| Dec 31, 2022 | -15.23% |
| Sep 30, 2022 | 6.66% |
| Jun 30, 2022 | -36.34% |
| Mar 31, 2022 | -2.20% |
| Dec 31, 2021 | -9.61% |
| Sep 30, 2021 | -16.61% |
| Jun 30, 2021 | -21.17% |
| Mar 31, 2021 | 13.39% |
| Dec 31, 2020 | -84.85% |
| Sep 30, 2020 | -264.92% |
| Jun 30, 2020 | 78.38% |